EMERGENT BIOSOLUTIONS INC. Income Taxes Receivable, Current
EMERGENT BIOSOLUTIONS INC. (EBS) had Income Taxes Receivable, Current of $10.20 million as of 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2020-05-01
- 2020-03-31: Income Taxes Receivable, Current $10.20M.
- 2019-12-31: Income Taxes Receivable, Current $4.60M.
- 2018-12-31: Income Taxes Receivable, Current $8.60M.
- 2018-09-30: Income Taxes Receivable, Current $0.00.
| Period end | Income Taxes Receivable, Current | Income Taxes Receivable, Current as first filed |
|---|---|---|
| 2020-03-31 | $10.20M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $4.60M 10-Q · filed 2020-05-01 | |
| 2018-12-31 | $8.60M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $7.04M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $2.40M 10-K · filed 2019-02-22 | $2.43M 10-K · filed 2018-02-23 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $6.12M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $6.77M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $10.00M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $11.83M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $9.18M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $3.77M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $6.57M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $3.43M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $13.14M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $17.02M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $1.36M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $8.26M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $16.67M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $17.80M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $5.65M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $588.00K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $6.50M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $10.76M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-10 | |
| 2012-09-30 | $9.62M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $10.42M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $19.80M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $9.51M 10-K · filed 2013-03-08 | |
| 2011-09-30 | $24.49M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $17.14M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $8.73M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |